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Superantigena member of the Coronaviridae, is a respiratory pathogen in poultry. We found
that in vitro stimulation with IBV resulted in ChIFN-γ production in splenocytes of both infected birds and
uninfected birds. The non-speciﬁc stimulation did not occur when other avian viruses or other coronaviruses
were used or when mammalian cells were stimulated with IBV. Inactivation of IBV reduced ChIFN-γ
production, but ChIFN-γ remained elevated compared to unstimulated cells. An increase in ChIFN-γ mRNA
was detected in splenocytes from IBV-infected and uninfected chickens as early as 1 h after stimulation with
IBV. These results indicate that IBV acts as a polyclonal stimulus, inducing a rapid production of IFN-γ even
without previous exposure to the virus.
© 2008 Elsevier Inc. All rights reserved.IntroductionInfectious Bronchitis Virus is a coronavirus of limited structural
complexity that causes an acute, highly contagious respiratory disease
in poultry. As well as being an economically relevant pathogen in
poultry, IBV also bears close resemblance to the human pathogen
severe acute respiratory syndrome coronavirus (SARS-CoV; Cavanagh,
2003). In order to study the immune responses to IBV in poultry in
more detail, techniques are required that provide information about
the immune cells participating to the response on a single-cell level. It
has been shown that CD8+T cells play an important role in controlling
IBV infection (Collisson et al., 2000). Furthermore, it is known that
interferons are actively involved in the immune response against IBV
(Hackney et al., 2003; Otsuki et al., 1988). Most of the techniques that
are available to study T-cell responses in poultry do not provide any
information about the response on single-cell level. We developed an
ELISPOT assay and intracellular cytokine staining for the detection of
ChIFN-γ production, which is often used as an indicator of T-cell
activity (Ariaans et al., 2008b).
This ELISPOT assay allowed for the quantiﬁcation of immune cell
activity after mitogen stimulation and after vaccinationwith Newcastle
Disease Virus (NDV), providing information about infection status of
poultry and about the kinetics of the infection. An infection experimentol of Medicine and Biomedical
l rights reserved.was set up in which ChIFN-γ production by splenocytes from IBV-
uninfected chickenswas compared to that of IBV-infected chickens after
in vitro restimulation with virulent IBV strain M41. Contrary to our
expectations, the results indicated that ChIFN-γproductionwasnot only
signiﬁcantly increased in splenocytes of IBV-infected chickens after in
vitro restimulation with IBV, but also in splenocytes of IBV-uninfected
chickens. Based on these ﬁndings, we investigated the possibility of
polyclonal stimulation by IBV in more detail.
Results
White Leghorn chickens were inoculated with virulent IBV strain
M41 and at four different time points after inoculation spleens were
harvested. Splenocytes of IBV-infected and uninfected chickens were
incubated for 48 h with ConA, PMA and ionomycin, and different
coronaviruses. ChIFN-γ production increased signiﬁcantly after in
vitro restimulation with IBV in both the IBV-infected and uninfected
chickens (Fig. 1). Two mammalian coronaviruses did not cause an
increase in ChIFN-γ production, indicating that the observed effect
was speciﬁc for IBV and not for coronaviruses in general.
To determine if the IBV-induced ChIFN-γ productionwas caused by
virus invasion and replication or an exclusively cell-mediated response
to IBV, the virus was inactivated by exposure to ultraviolet light (Fig. 1,
13 dpi). ChIFN-γ production after exposure to the inactivated IBV did
decrease in the IBV-uninfected birds when compared to IBV-infected
birds, but it was still higher than in unstimulated cells.
Although a decrease in ChIFN-γ productionwas detected after UV-
inactivation of IBV, it cannot be excluded that the immune response in
Fig.1. ELISPOT assay tomeasure ChIFN-γ production by splenocytes of IBV-uninfected (black bars; n=3) versus IBVM41-infected (white bars; n=6) chickens at 3, 5, 7, or 13 days post-
infection. Splenocytes were added to ChIFN-γ-coated wells and stimulated for 48 hwith medium, ConA (10 μg/ml), PMA (100 ng/ml) and ionomycin (500 ng/ml), MHV (106 pfu), FIPV
(106 pfu), IBVM41 (105 EID50), or UV-inactivated IBVM41 (IBV-UV,13 dpi; 105 EID50). Spot counts represent the number of ChIFN-γ secreting cells. Each bar represents the average of
three samples per chicken, plus standard deviation.
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point. The experiment was repeated with IBV and with another
chicken virus, NDV, both live and UV-inactivated. Splenocytes of an
unvaccinated chicken and a chicken that had been vaccinated for both
IBV and NDV 4 months prior to the experiment were restimulated in
vitrowith different concentrations of either virulent or UV-inactivated
IBV M41 or NDV (Fig. 2).
Only the splenocytes from the NDV-vaccinated chicken produced
ChIFN-γ after NDV restimulation, and hardly any response to the UV-
inactivated virus was detected. In contrast, both the IBV-vaccinated
and the unvaccinated chicken showed a dose-dependent response to
restimulation with IBV, with no discernable difference between
treated and untreated virus in the vaccinated chicken. Stimulation
with UV-inactivated IBV resulted in decreased ChIFN-γ production in
the unvaccinated chicken compared to the vaccinated chicken, but the
response was still elevated compared to the unstimulated control.
To test if the observed effect is a speciﬁc interaction between the
virus and its natural host, or if IBV can activate leukocytes regardless of
the species fromwhich the cells were obtained, we stimulated chicken
and cow leukocytes with mitogens and different avian viruses (Fig. 3).Fig. 2. ELISPOT assay to measure ChIFN-γ. Splenocytes of an unvaccinated (black bars)
and an IBV- and NDV-vaccinated White Leghorn chicken (white bars) were stimulated
in triplicate with three different doses of untreated or UV-inactivated IBV M41 or NDV.
Bars marked with ⁎ show a signiﬁcant difference (pb0.05) between vaccinated and
unvaccinated birds. Bars marked with ‘a’ show a signiﬁcant difference between the
vaccinated and unvaccinated birds on the one hand and the unstimulated controls on
the other. Bars marked with ‘b’ show a signiﬁcant difference between vaccinated birds
and unstimulated controls.Splenocytes of an IBV- and NDV-vaccinated chicken produced ChIFN-γ
after incubation with IBV and UV-inactivated IBV, whereas cow PBMC
did not show any response. A third poultry virus, REV, did not induce
IFN-γ. These results demonstrate that the immune activation by IBV is
species-speciﬁc, and that two other poultry viruses thatwehave tested
(NDV and REV) do not cause a similar rapid immune activation upon
ﬁrst exposure.
IBV is known to induce rapid production of type-I IFNs by chicken
leukocytes in both naïve and IBV-infected chickens (Pei et al., 2001).
Type-I IFNs are heat-stable, whereas IFN-γ is heat-sensitive. To
exclude that the anti-IFN-γ antibodies used in our ELISPOT assay are
cross-reactingwith type-I IFNs or other heat-stable antigens produced
by IBV-infected cells, we tested the effect of heat inactivation. Chicken
splenocytes were cultured for 48 h in the presence of different stimuli,
the supernatants were collected and part of the samples heat-
inactivated at 65 °C for 30 min. We tested all the samples using a
commercial ELISA for chIFN-γ detection (Fig. 4).
After heat-inactivation, ChIFN-γ levels in the supernatants
decreased signiﬁcantly when compared to untreated supernatants,
conﬁrming that the observed signal was indeed speciﬁc for ChIFN-γ
and not due to cross-reactivity with type-I IFNs or other heat-stableFig. 3. ELISPOT assay to measure the production of IFN-γ by splenocytes (black bars) of
an IBV- and NDV-vaccinated White Leghorn chicken and by cow PBMC (white bars) in
triplicate after in vitro stimulation with ConA (10 μg/ml), PMA (100 ng/ml) and
ionomycin (500 ng/ml), NDV (105 EID50), REV (105 EID50), IBV M41 (105 EID50), or UV-
inactivated IBVM41 (105 EID50). Bars marked with ⁎ are signiﬁcantly different (pb0.05).
Fig. 4. Chicken splenocytes were incubated in triplicate for 48 h with medium or IBVM41 (105 and 104 EID50). After 48 h, culture supernatants were collected and half of the samples
were incubated at 65 °C for 30 min. Supernatants were tested using a commercial ELISA for ChIFN-γ. Recombinant ChIFN-γ protein (10 ng/ml) with or without heat treatment was
included as a control. Groups with different letters are signiﬁcantly different (pb0.05).
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the ChIFN-γ levels were around 200–250 pg/ml, whereas after
inactivation these levels dropped below the detection limit.
To ensure that the induction of ChIFN-γ was not due to
contaminating components derived from the allantois ﬂuid in which
the virus was grown or from the production process, the virus was
puriﬁed with a sucrose gradient and tested in an ELISPOT assay.
Splenocytes from four IBV-uninfected chickens were stimulated with
puriﬁed and unpuriﬁed IBV (Fig. 5). A fraction of the sucrose gradient
obtained from outside the IBV band and allantois ﬂuid from an IBV-
uninfected egg (10×diluted in PBS) were also included. All splenocyte
cultures showed a signiﬁcant increase in ChIFN-γ production after
stimulation with IBV M41 before and after sucrose-puriﬁcation, with
no signiﬁcant differences between them. Incubation with a fraction of
the sucrose gradient obtained from outside the IBV band (‘residue’)
and with IBV-free allantois ﬂuid did show any effect. We therefore
conclude that the increase in ChIFN-γ production is caused by the IBV
itself and not by other components.Fig. 5. ELISPOT for detection of ChIFN-γ produced by splenocytes of 4 chickens after 24 h
incubation with the following stimuli: culture medium, ConA (10 μg/ml), PMA (100 ng/
ml) and ionomycin (500 ng/ml), 105 EID50 IBVM41 before (IBV pre) sucrose puriﬁcation,
IBV M41 pooled from the 3 IBV-richest sucrose fractions (IBV post1, ∼105 EID50) and
pooled from 3 surrounding fractions (IBV post2, ∼105 EID50), a pool of 3 sucrose
fractions outside the IBV band (residue, same volume as ‘post2’ sucrose fraction), and
allantois from an IBV-uninfected egg. Groups with different letters are signiﬁcantly
different (pb0.05).To study the kinetics withwhich IFN-γwas induced, we performed
quantitative RT-PCR (qPCR) for detection of ChIFN-γ mRNA in
commercial broilers (Fig. 6) and layer chickens (Fig. 7). Both layers
and broilers show increased ChIFN-γ mRNA expression after IBV
stimulation. An increase in ChIFN-γmRNA expressionwas detected as
early as 2 h after stimulation with virulent IBV M41 and with IBV
vaccine strain H120 in splenocytes of layer birds.
Discussion
IFN-α and IFN-β, both type-I interferons, are important in the
innate immune defence against virus infection and are quickly
upregulated after infection with viruses (Kawai and Akira, 2006).
IFN-γ, a type-II interferon, is associated with adaptive immune
responses and as such would be expected to be upregulated later in
the immune response (Takaoka and Yanai, 2006). In contrast, we
observed a rapid increase in ChIFN-γ production within 24 h after
stimulation of chicken splenocytes with coronavirus IBV strain M41,
and an increased expression of ChIFN-γ mRNA as early as 1 h afterFig. 6. Real-time quantiﬁcation of ChIFN-γ mRNA expression by splenocytes collected
7 days after IBV infection from four IBV-infected and four IBV-uninfected 5 wk old
commercial broiler chickens, 6 h after stimulationwith PMA (100 ng/ml) and ionomycin
(500 ng/ml), or IBV M41 (105 EID50). Bars represent the mean fold increase (plus
standard deviation) in ChIFN-γ mRNA production compared to unstimulated
splenocytes. All groups are signiﬁcantly different from the unstimulated splenocytes
(⁎pb0.05; ⁎⁎pb0.01).
Fig. 7. Real-time quantiﬁcation of ChIFN-γ mRNA expression by splenocytes from four
IBV-infected layer chickens, at four different time points after stimulation with IBV M41
(105 EID50) or IBV H120 (105 EID50). Each bar represents the mean fold increase (plus
standard deviation) in ChIFN-γ mRNA production compared to unstimulated
splenocytes from the same birds.
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splenocytes of chickens that had previously been exposed to IBV, but
also in splenocytes of IBV-naïve chickens. Furthermore, two chicken
viruses that are not members of the Coronaviridae family, the avian
paramyxovirus NDV and the retrovirus REV, did not induce ChIFN-γ
production in splenocytes of uninfected chickens. IBV did not induce
production of IFN-γ by leukocytes of mammalian origin, cow PBMC.
This indicates that the observed IFN-γ production appears to be a
speciﬁc interaction between IBV and its natural host, and not an effect
generally observed after exposure of non-avian leukocytes to IBV, or of
chicken leukocytes to non-avian coronaviruses or to other avian
viruses.
We also observed an increase in IFN-γ production after FIPV
stimulation at 13 dpi in IBV-infected chickens, which might be due to
cross-presentation of certain conserved epitopes shared between the
IBV and FIPV. It has been shown that coronaviruses are not necessarily
restricted to one host species, as SARS-CoV can replicate in humans,
mice, hamsters and ferrets (Roberts et al., 2008), and bovine
coronavirus was shown to replicate in turkeys and cause enteritis
(Ismail et al., 2001).
To ensure that the observed response was indeed due to ChIFN-γ
detection and not to type-I interferons, samples were heated to 65 °C
after incubation. This inactivates IFN-γ but not type-I interferons
(Lowenthal et al., 2001). After heat-treatment, the concentration of
ChIFN-γ protein in the IBV-stimulated samples dropped to back-
ground levels, indicating that the observed response is indeed ChIFN-
γ-speciﬁc and not due to type-I interferons.
In virus taxonomy, coronaviruses are currently assigned into four
different groups, with groups 1 and 2 consisting of various
mammalian coronaviruses, group 3 formed exclusively by avian
coronaviruses such as IBV, Turkey coronavirus (TCoV) and Pheasant
coronavirus, and group 4 currently only containing the recently
discovered human coronavirus SARS-CoV (Cavanagh, 2007). Chicken
splenocytes were in vitro stimulated with members of the other
coronavirus groups that have mammalian hosts, the group 1
coronavirus FIPV and group 2 coronavirus MHV. Both viruses did
not induce ChIFN-γ production by chicken splenocytes. For MHV
several studies have shown a clear difference in IFN-γ production
between infected and uninfected mice by ELISA and qPCR (Hooks et
al., 2003; Lucchiari et al., 1991). Elevated levels of IFN-γ mRNA were
detected in a pilot study with a FIPV-infected cat when compared to
uninfected cats (Kiss et al., 2004).
Castilletti et al. (2005) showed that the group 4 human SARS-CoV,
which is thought to be closely related to IBV, induced both IFN-α andIFN-γ mRNA and protein after stimulation of PBMC from healthy
donors in a dose-dependent manner within 24 h, without the need for
viral replication. They suggest that exposure of PBMC to high virus
titers in vivo at the site of infection is biologically likely and as such
concomitant activation of IFN-α and IFN-γ after ﬁrst-time exposure to
relatively high levels of coronavirus might be relevant to the
pathogenesis of the disease. A comparison between PBMC of healthy
donors and SARS patients was not made, and it therefore remains
unknown whether the kinetics of IFN-γ production after exposure to
SARS-CoV is similar in SARS patients and healthy donors.
Both IBV and SARS-CoV infect and replicate in the respiratory tract,
and have been reported to spread to other enteric tissues such as the
gastrointestinal tract (Cavanagh, 2007; Navas-Martin and Weiss,
2004). Infection with these viruses leads to leukocyte inﬂux and
damage of respiratory tract epithelium. Matthijs et al. (in press) found
very high numbers of macrophages and CD4+ T cells in trachea and
lung of IBV H120 and M41 infected birds. The local immune
deregulation might in turn give rise to enhanced susceptibility to
secondary bacterial infections, such as colibacillosis in poultry after
IBV infection, or to organ destruction and pneumonia-like symptoms
in the case of SARS. Interestingly, highly elevated levels of IFN-γ and
related cytokines and chemokines, a so-called “cytokine storm”, were
found already at the day of fever onset in SARS patients (Huang et al.,
2005), and improperly modulated IFN type I and II responses are
thought to be closely linked to the clinical course of SARS (Cameron et
al., 2007). These elevated cytokine and chemokine levels could be one
of the causes of the observed leukocyte inﬂux in the lungs and this in
turn could result in the organ destruction and immune system
exhaustion that are a hallmark of SARS. Unfortunately, the cytokine
kinetics in the SARS study were examined at a later time interval than
in our study and can therefore not support or disprove the possibility
of SARS-CoV acting as a polyclonal stimulus.
We did not investigate which cells were involved in the observed
rapid ChIFN-γ production. Apart from certain T cell sub-populations,
NK cells are known to be major producers of IFN-γ (Yenan and
Bryceson, 2006). However, as opposed to mammals, NK cells can only
be found in very low numbers in the spleen or peripheral blood of
birds (Göbel et al., 2001), and little is known about their activation
kinetics. Identifying the cells involved in the rapid ChIFN-γ production
after IBV stimulation will be an important focus for further research.
In conclusion, we have shown a rapid increase in ChIFN-γ
production by chicken leukocytes after in vitro stimulation with IBV.
This increase is independent of the infection status of the chicken and
appears to be IBV-speciﬁc, as we did not observe this effect with other
chicken viruses, other coronaviruses or components from allantoic
ﬂuid from which the virus was isolated. The observed effect suggests
that IBV acts as a polyclonal stimulus on chicken immune cells.
Materials and methods
Animals
Commercial White Leghorn chickens and Mycoplasma-free broiler
chickens (Cobb) were housed in groups and fed ad libitum on
commercial feed. Chickens were housed, handled and treated
following approval by the Animal Experimental Committee of the
Veterinary Faculty of Utrecht University, The Netherlands, in accor-
dance with the Dutch regulation on experimental animals.
Virus
The virulent Massachusetts IBV strain M41 was obtained from
Intervet, Boxmeer, theNetherlands, as freeze-driedvials containing108.3
EID50/1.2ml/vial. Thevirushadbeenpassaged twice in SPFembryonated
eggs. The IB vaccine virus H120 was obtained as commercial freeze-
dried 1000 doses vials which contained at least 103.0 EID50 (egg infective
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inocula were prepared in distilled water and contained at least 103.0
EID50/ml of H120 virus and 104.6 EID50/ml of M41 virus. NDV was
obtained as commercial freeze-dried vials which contained at least 106
EID50 per dose (Nobilis; ND clone 30). Feline Infectious Peritonitis Virus
(FIPV) and Mouse Hepatitis Virus (MHV; both 108 pfu/ml) were a kind
gift from theVirologyDepartment of the Faculty of VeterinaryMedicine,
Utrecht University. Reticulo-Endotheliosis Virus (REV-C; 5×106 TCID/
ml) was a kind gift from Dr. G. Koch (CIDC-Lelystad). All inocula were
prepared in LPS-free PBS prior to in vitro stimulation at a concentration
of 106 EID50 or pfu/ml.
IBV M41 was puriﬁed using a sucrose gradient (Cornelissen et al.,
1997; Koopmans et al., 1986). The gradient consisted of layers of 20–
50% sucrose (top to bottom) in TES-V (20 mM TRIS–HCl at pH 7.3,
1 mM EDTA, 100 mM NaCl). This gradient was autoclaved, left to
linearise at 4 °C overnight, loaded with an IBV virus sample and
centrifuged at 15,000 ×g for 3 h, 4 °C. Gradient fractions were
collected from the bottom (50% sucrose solution) to the top (20%)
with a ﬂuid pump. For in vitro restimulation, inactivation of virus was
achieved by direct exposure of the virus to UV illumination (∼1 mW/
cm3) for 1 h (Ravindra et al., 2008; Stern and Sefton, 1982). Egg
allantois ﬂuid was a kind gift from Dr. J. de Wit (GD-Animal Health
Service, Deventer).
ELISPOT assay
Preparation of splenocytes was described before in Ariaans et al.
(2008b). Brieﬂy, spleen tissue was squeezed through 70 μm mesh in
RPMI1640 culture medium containing 2% FCS to prepare a single cell
suspension. Splenocytes were isolated by density gradient centrifuga-
tion using FICOLL-Hypaque.
The ELISPOT assay has been described by Ariaans et al. (2008b).
Brieﬂy, MultiScreenTM-IP 96-well plates were coated with mouse-anti-
ChIFN-γ, blocked and splenocytes were seeded at 3×105 cells/well in
triplicate in culture medium. Cells were incubated in the presence of
either culturemedium ormedium supplementedwith Concanavalin A
(ConA; 10 μg/ml), phorbol 12-myristate 13-acetate (PMA; 100 ng/ml)
and ionomycin (500 ng/ml), or virus and incubated for 24 or 48 h at
41 °C, 5% CO2. ChIFN-γ was detected by incubation with biotinylated
mouse-anti-ChIFN-γ and streptavidin-alkaline phosphatase. The
assay was developed using BCIP/NBT substrate, and analyzed using
the A·EL·VIS machine and the Eli.Analyse software (Version 4.0) that
allows for automated counting of the number of spots based on size
and intensity. The cow PBMC ELISPOT was performed as described by
Koets et al. (2006).
ELISA for ChIFN-γ detection
A total of 2×106 splenocytes per chickenwere incubated for 48 h in a
24-wells plate in 500 μl of culture medium at 41 °C, 5% CO2, without
stimulation or in the presence of ConA. Afterwards, supernatants were
tested for ChIFN-γ using a commercial sandwich ELISA kit (Biosource
International, California, USA) according to manufacturer's instructions.
Real-time quantitative reverse transcription-polymerase chain reaction
(RT-PCR)
RNA samples isolated from spleenwere screened for mRNA encoding
ChIFN-γ, as described in Ariaans et al. (2008a). Brieﬂy, total RNA was
isolated using the RNeasyMini Kit (Qiagen) following themanufacturer's
instructions. Reverse transcription was performed using iScript cDNA
Synthesis Kit (Biorad). The forward primer (5′-GTGAAGAAGGTGAAAGA-
TATCATGGA-3′) and reverse primer (5′-GCTTTGCGCTGGATTCTCA-3′)
and the probe (5′-FAM-TGGCCAAGCTCCCGATGAACGA-TAMRA-3′) for
ChIFN-γ were designed according to Kaiser et al. (Kaiser et al., 2003).
Ampliﬁcation and detection of speciﬁc products was achieved with theMyiQ Single-Color Real-Time PCR Detection System (Bio-Rad). Results
were expressed as fold change between samples (Philbin et al., 2005).
Statistical analysis
Statistical analysis was performed using GraphPad Prism 5 for
Windows. Analysis of datawas performed using aMann-Whitney test.
Results were considered statistically signiﬁcant if p≤0.05.
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